Cargando…
Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes
Approximately, 35% of women with Gestational Diabetes (GDM) progress to Type 2 Diabetes (T2D) within 10 years. However, links between GDM and T2D are not well understood. We used a well-characterised GDM prospective cohort of 1035 women following up to 8 years postpartum. Lipidomics profiling coveri...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417169/ https://www.ncbi.nlm.nih.gov/pubmed/32748787 http://dx.doi.org/10.7554/eLife.59153 |
_version_ | 1783569437601824768 |
---|---|
author | Lai, Mi Al Rijjal, Dana Röst, Hannes L Dai, Feihan F Gunderson, Erica P Wheeler, Michael B |
author_facet | Lai, Mi Al Rijjal, Dana Röst, Hannes L Dai, Feihan F Gunderson, Erica P Wheeler, Michael B |
author_sort | Lai, Mi |
collection | PubMed |
description | Approximately, 35% of women with Gestational Diabetes (GDM) progress to Type 2 Diabetes (T2D) within 10 years. However, links between GDM and T2D are not well understood. We used a well-characterised GDM prospective cohort of 1035 women following up to 8 years postpartum. Lipidomics profiling covering >1000 lipids was performed on fasting plasma samples from participants 6–9 week postpartum (171 incident T2D vs. 179 controls). We discovered 311 lipids positively and 70 lipids negatively associated with T2D risk. The upregulation of glycerolipid metabolism involving triacylglycerol and diacylglycerol biosynthesis suggested activated lipid storage before diabetes onset. In contrast, decreased sphingomyelines, hexosylceramide and lactosylceramide indicated impaired sphingolipid metabolism. Additionally, a lipid signature was identified to effectively predict future diabetes risk. These findings demonstrate an underlying dyslipidemia during the early postpartum in those GDM women who progress to T2D and suggest endogenous lipogenesis may be a driving force for future diabetes onset. |
format | Online Article Text |
id | pubmed-7417169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-74171692020-08-12 Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes Lai, Mi Al Rijjal, Dana Röst, Hannes L Dai, Feihan F Gunderson, Erica P Wheeler, Michael B eLife Human Biology and Medicine Approximately, 35% of women with Gestational Diabetes (GDM) progress to Type 2 Diabetes (T2D) within 10 years. However, links between GDM and T2D are not well understood. We used a well-characterised GDM prospective cohort of 1035 women following up to 8 years postpartum. Lipidomics profiling covering >1000 lipids was performed on fasting plasma samples from participants 6–9 week postpartum (171 incident T2D vs. 179 controls). We discovered 311 lipids positively and 70 lipids negatively associated with T2D risk. The upregulation of glycerolipid metabolism involving triacylglycerol and diacylglycerol biosynthesis suggested activated lipid storage before diabetes onset. In contrast, decreased sphingomyelines, hexosylceramide and lactosylceramide indicated impaired sphingolipid metabolism. Additionally, a lipid signature was identified to effectively predict future diabetes risk. These findings demonstrate an underlying dyslipidemia during the early postpartum in those GDM women who progress to T2D and suggest endogenous lipogenesis may be a driving force for future diabetes onset. eLife Sciences Publications, Ltd 2020-08-04 /pmc/articles/PMC7417169/ /pubmed/32748787 http://dx.doi.org/10.7554/eLife.59153 Text en © 2020, Lai et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Human Biology and Medicine Lai, Mi Al Rijjal, Dana Röst, Hannes L Dai, Feihan F Gunderson, Erica P Wheeler, Michael B Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes |
title | Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes |
title_full | Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes |
title_fullStr | Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes |
title_full_unstemmed | Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes |
title_short | Underlying dyslipidemia postpartum in women with a recent GDM pregnancy who develop type 2 diabetes |
title_sort | underlying dyslipidemia postpartum in women with a recent gdm pregnancy who develop type 2 diabetes |
topic | Human Biology and Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417169/ https://www.ncbi.nlm.nih.gov/pubmed/32748787 http://dx.doi.org/10.7554/eLife.59153 |
work_keys_str_mv | AT laimi underlyingdyslipidemiapostpartuminwomenwitharecentgdmpregnancywhodeveloptype2diabetes AT alrijjaldana underlyingdyslipidemiapostpartuminwomenwitharecentgdmpregnancywhodeveloptype2diabetes AT rosthannesl underlyingdyslipidemiapostpartuminwomenwitharecentgdmpregnancywhodeveloptype2diabetes AT daifeihanf underlyingdyslipidemiapostpartuminwomenwitharecentgdmpregnancywhodeveloptype2diabetes AT gundersonericap underlyingdyslipidemiapostpartuminwomenwitharecentgdmpregnancywhodeveloptype2diabetes AT wheelermichaelb underlyingdyslipidemiapostpartuminwomenwitharecentgdmpregnancywhodeveloptype2diabetes |